SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-011486
Filing Date
2024-08-08
Accepted
2024-08-08 09:30:13
Documents
15
Period of Report
2024-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K viri-20240808x8k.htm   iXBRL 8-K 41959
2 EX-99.1 viri-20240808xex99d1.htm EX-99.1 108058
3 GRAPHIC viri-20240808xex99d1001.jpg GRAPHIC 11583
  Complete submission text file 0001558370-24-011486.txt   295457

Data Files

Seq Description Document Type Size
4 EX-101.SCH viri-20240808.xsd EX-101.SCH 3247
5 EX-101.LAB viri-20240808_lab.xml EX-101.LAB 15916
6 EX-101.PRE viri-20240808_pre.xml EX-101.PRE 10043
17 EXTRACTED XBRL INSTANCE DOCUMENT viri-20240808x8k_htm.xml XML 4803
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Virios Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

IRS No.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39811 | Film No.: 241186397
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)